There is clear evidence that the NKG2A/HLA-E complex inhibits the immune surveillance and impairs the clearance of tumor cells by the cytotoxic NK and CD8+ T cells (Andre et al. 2018; Kamiya et al. 2019; Fisher et al. 2022). The gene discussed is CD8A; the disease is neoplasm.